ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Austin, TX, USA:

Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Acute myeloid leukemia (AML) is the second most common type of leukemia diagnosed in adults and children ...

Enrolling
Acute Myeloid Leukemia
Drug: ABBV-787

Phase 1

AbbVie
AbbVie

Austin, Texas, United States and 23 other locations

The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SG...

Enrolling
Acute Myeloid Leukemia
High-Risk and Very High-Risk Myelodysplastic Syndromes
Drug: SGR-2921

Phase 1

Schrödinger, Inc.

Austin, Texas, United States and 11 other locations

(mCRPC), higher risk myelodysplastic syndrome (HRMDS), acute myeloid leukemia (AML) and newly diagnosed intermed...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Drug: ASTX727
Drug: KPT-8602

Phase 1, Phase 2

Karyopharm Therapeutics
Karyopharm Therapeutics

Austin, Texas, United States and 45 other locations

This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...

Active, not recruiting
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Drug: Docetaxel
Drug: Aplitabart (IGM-8444)

Phase 1

IGM Biosciences
IGM Biosciences

Austin, Texas, United States and 57 other locations

This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azaci...

Enrolling
Myeloid Sarcoma
Mixed Phenotype Acute Leukemia
Drug: Daunorubicin
Drug: Cytarabine

Phase 1

Kura Oncology

Austin, Texas, United States and 27 other locations

Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...

Active, not recruiting
Myelodysplastic Syndrome (MDS)
Drug: Placebo
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Austin, Texas, United States and 221 other locations

with bone marrow from a deceased donor in patients with acute leukemias. Patients will either receive myeloablative conditioning or...

Enrolling
Acute Biphenotypic Leukemia
Acute Leukemia
Other: Ossium HPC Marrow, Bone Marrow Transplant
Other: Pre-transplant conditioning - Myeloablative (MAC)

Phase 1, Phase 2

Ossium Health

Austin, Texas, United States and 3 other locations

azacitidine. (An event is defined as death or transformation to AML in participants with MDS or CMML, whichever occurs first, and is defined...

Active, not recruiting
Leukemia, Myeloid, Acute
Leukemia, Myelomonocytic, Chronic
Drug: Pevonedistat
Drug: Azacitidine

Phase 3

Takeda
Takeda

Austin, Texas, United States and 240 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems